GlassScriptPhysician profile
Alexander Thomas Hynes
NPI 1376076489
$16,649.20
in general payments reported to CMS, 2019-2025
12 companies · $2,873 in 2025
The $2,873 reported for 2025 was more than what 84% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,627 · 2022: $4,775 · 2023: $2,926 · 2024: $4,448 · 2025: $2,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,374 · Travel and Lodging: $873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,373.65 |
| Travel and Lodging | $873.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,645.88 | 2022-2025 | Proclaim, Octrode, Eterna |
| Boston Scientific Corporation | $3,234.24 | 2021-2025 | Intracept |
| Spinal Simplicity, LLC | $1,516.07 | 2022-2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $1,151.89 | 2021-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $392.87 | 2022 | |
| Vertos Medical, INC. | $292.38 | 2023-2024 | Mild Device Kit |
| Si-Bone, INC. | $120.28 | 2022 | |
| Globus Medical, INC. | $111.20 | 2025 | Senza |
| Relievant Medsystems, INC. | $103.31 | 2022-2023 | Intracept |
| Spr Therapeutics, INC | $47.32 | 2023 | Sprint Pns System |
| Curonix LLC | $17.53 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Foundation Fusion Solutions, LLC | $16.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Hynes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.